Dr. Leigh Verbois

S. Leigh Verbois, Ph.D. serves as Director of the Office of Drug Security, Integrity and Response within CDER’s Office of Compliance, where she provides strategic leadership of pharmaceutical import, export, recall, and supply chain compliance and enforcement programs for the U.S. Food and Drug Administration. Dr. Verbois previously served as the Director of the Office of Global Operations in the Office of Global Policy and Strategy and Acting Assistant Commissioner for International Programs, where she provided strategic direction and leadership for operations, policy and engagement of FDA’s diplomatic missions to protect and promote public health. She also served in Beijing as FDA Country Director for the People’s Republic of China where she led FDA’s efforts in China. Before posting to China, she oversaw FDA regulatory engagement with countries in the Asia-Pacific (excepting China and India), Middle East, Africa and Canada as Director of the Office of Regional and Country Affairs within FDA’s Office of International Programs. Dr. Verbois began her FDA career as a reviewer in CDER’s Office of New Drugs. Subsequently, she developed and directed strategies, activities, and policies to reduce threats to the global drug supply chain through increased transparency and accountability, effective enforcement, and promotion of proactive industry vigilance and voluntary compliance in CDER’s Office of Compliance. Dr. Verbois previously served in the Office of Global Regulatory Operations and Policy as Senior Advisor, Acting Assistant Commissioner for Compliance Policy in the Office of Regulatory Affairs and Acting Deputy Director of FDA’s China Office. In these capacities, she guided multidisciplinary teams to facilitate strategic decisions, manage resources, and develop policy that is data driven and risk-based for all FDA- regulated commodities.